Adaptive Biotechnologies Corp Stock Price History
| ADPT Stock | USD 8.42 0.24 2.77% |
Below is the normalized historical share price chart for Adaptive Biotechnologies Corp extending back to June 27, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Adaptive Biotechnologies stands at 8.42, as last reported on the 25th of March, with the highest price reaching 8.74 and the lowest price hitting 8.37 during the day.
If you're considering investing in Adaptive Stock, it is important to understand the factors that can impact its price. Adaptive Biotechnologies appears to be moderately volatile, given 3 months investment horizon. Adaptive Biotechnologies secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of standard deviation over the last 3 months. By analyzing Adaptive Biotechnologies' technical indicators, you can evaluate if the expected return of 0.58% is justified by implied risk. Please makes use of Adaptive Biotechnologies' risk adjusted performance of 0.0949, and Mean Deviation of 3.63 to double-check if our risk estimates are consistent with your expectations.
At this time, Adaptive Biotechnologies' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 784.4 M in 2025, whereas Common Stock Total Equity is likely to drop slightly above 10.3 K in 2025. . At this time, Adaptive Biotechnologies' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.19 in 2025, whereas Price To Operating Cash Flows Ratio is likely to drop (9.73) in 2025. Adaptive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of June 2019 | 200 Day MA 5.5545 | 50 Day MA 7.7388 | Beta 1.532 |
Adaptive |
Sharpe Ratio = 0.1115
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ADPT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.24 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.58 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Adaptive Biotechnologies is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adaptive Biotechnologies by adding it to a well-diversified portfolio.
Price Book 6.3476 | Enterprise Value Ebitda (1.00) | Price Sales 7.1901 | Shares Float 96.5 M | Wall Street Target Price 9.7143 |
Adaptive Biotechnologies Stock Price History Chart
There are several ways to analyze Adaptive Stock price data. The simplest method is using a basic Adaptive candlestick price chart, which shows Adaptive Biotechnologies price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 24, 2025 | 8.66 |
| Lowest Price | December 31, 2024 | 6.0 |
Adaptive Biotechnologies March 25, 2025 Stock Price Synopsis
Various analyses of Adaptive Biotechnologies' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Adaptive Stock. It can be used to describe the percentage change in the price of Adaptive Biotechnologies from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Adaptive Stock.| Adaptive Biotechnologies Price Rate Of Daily Change | 0.97 | |
| Adaptive Biotechnologies Price Action Indicator | (0.25) | |
| Adaptive Biotechnologies Accumulation Distribution | 76,289 | |
| Adaptive Biotechnologies Price Daily Balance Of Power | (0.65) |
Adaptive Biotechnologies March 25, 2025 Stock Price Analysis
Adaptive Stock Price History Data
The price series of Adaptive Biotechnologies for the period between Wed, Dec 25, 2024 and Tue, Mar 25, 2025 has a statistical range of 2.69 with a coefficient of variation of 10.35. The prices are distributed with arithmetic mean of 7.43. The median price for the last 90 days is 7.62.| Open | High | Low | Close | Volume | ||
| 03/25/2025 | 8.66 | 8.74 | 8.37 | 8.42 | 1,802,059 | |
| 03/24/2025 | 8.57 | 9.01 | 8.43 | 8.66 | 2,479,386 | |
| 03/21/2025 | 8.05 | 8.66 | 7.80 | 8.40 | 2,854,537 | |
| 03/20/2025 | 7.48 | 7.81 | 7.38 | 7.75 | 1,864,435 | |
| 03/19/2025 | 7.30 | 8.08 | 7.26 | 7.56 | 1,832,894 | |
| 03/18/2025 | 7.44 | 7.57 | 6.92 | 7.35 | 2,352,291 | |
| 03/17/2025 | 7.26 | 7.68 | 7.11 | 7.54 | 1,677,207 | |
| 03/14/2025 | 7.30 | 7.45 | 7.04 | 7.28 | 1,821,258 | |
| 03/13/2025 | 7.50 | 7.58 | 6.96 | 7.17 | 1,275,012 | |
| 03/12/2025 | 7.59 | 7.89 | 7.43 | 7.62 | 2,454,883 | |
| 03/11/2025 | 6.71 | 7.50 | 6.26 | 7.49 | 2,567,697 | |
| 03/10/2025 | 7.17 | 7.31 | 6.45 | 6.67 | 2,781,203 | |
| 03/07/2025 | 7.68 | 7.92 | 7.08 | 7.35 | 2,535,894 | |
| 03/06/2025 | 7.61 | 8.27 | 7.48 | 7.77 | 1,572,644 | |
| 03/05/2025 | 6.97 | 8.49 | 6.79 | 8.03 | 4,921,867 | |
| 03/04/2025 | 7.76 | 8.30 | 7.65 | 8.12 | 1,802,891 | |
| 03/03/2025 | 8.30 | 8.50 | 7.86 | 8.10 | 1,269,633 | |
| 02/28/2025 | 8.09 | 8.32 | 7.92 | 8.26 | 1,197,016 | |
| 02/27/2025 | 8.41 | 8.58 | 8.16 | 8.16 | 870,664 | |
| 02/26/2025 | 8.55 | 8.94 | 8.20 | 8.36 | 1,421,163 | |
| 02/25/2025 | 8.52 | 8.52 | 7.92 | 8.42 | 1,714,525 | |
| 02/24/2025 | 8.23 | 8.53 | 8.03 | 8.42 | 1,271,314 | |
| 02/21/2025 | 8.47 | 8.62 | 8.09 | 8.27 | 1,430,002 | |
| 02/20/2025 | 8.39 | 8.69 | 8.20 | 8.33 | 1,653,009 | |
| 02/19/2025 | 8.14 | 8.66 | 8.11 | 8.37 | 2,447,493 | |
| 02/18/2025 | 8.69 | 8.95 | 8.09 | 8.27 | 2,320,096 | |
| 02/14/2025 | 8.60 | 8.74 | 8.19 | 8.33 | 2,005,065 | |
| 02/13/2025 | 7.65 | 8.56 | 7.36 | 8.52 | 2,063,638 | |
| 02/12/2025 | 7.55 | 7.71 | 6.97 | 7.55 | 1,650,494 | |
| 02/11/2025 | 7.63 | 7.92 | 7.44 | 7.80 | 1,778,458 | |
| 02/10/2025 | 7.87 | 7.89 | 7.37 | 7.68 | 1,897,237 | |
| 02/07/2025 | 8.03 | 8.19 | 7.66 | 7.84 | 1,556,259 | |
| 02/06/2025 | 8.17 | 8.31 | 7.75 | 8.01 | 1,478,639 | |
| 02/05/2025 | 7.41 | 8.17 | 7.38 | 8.05 | 2,042,361 | |
| 02/04/2025 | 7.66 | 7.86 | 7.27 | 7.37 | 1,119,704 | |
| 02/03/2025 | 7.51 | 7.99 | 7.45 | 7.70 | 939,794 | |
| 01/31/2025 | 7.96 | 8.24 | 7.68 | 7.75 | 901,499 | |
| 01/30/2025 | 7.86 | 8.21 | 7.80 | 7.86 | 723,655 | |
| 01/29/2025 | 7.86 | 8.04 | 7.45 | 7.71 | 885,113 | |
| 01/28/2025 | 7.73 | 7.93 | 7.45 | 7.85 | 754,855 | |
| 01/27/2025 | 7.84 | 8.15 | 7.57 | 7.70 | 937,585 | |
| 01/24/2025 | 8.08 | 8.26 | 7.88 | 7.99 | 897,616 | |
| 01/23/2025 | 7.99 | 8.23 | 7.65 | 8.13 | 2,217,997 | |
| 01/22/2025 | 7.45 | 8.33 | 7.31 | 8.01 | 3,294,830 | |
| 01/21/2025 | 6.95 | 7.50 | 6.95 | 7.45 | 1,765,790 | |
| 01/17/2025 | 7.04 | 7.08 | 6.65 | 6.81 | 1,048,286 | |
| 01/16/2025 | 7.19 | 7.19 | 6.51 | 6.92 | 1,659,352 | |
| 01/15/2025 | 6.35 | 7.28 | 6.34 | 7.16 | 3,006,067 | |
| 01/14/2025 | 6.56 | 6.65 | 5.98 | 6.07 | 971,149 | |
| 01/13/2025 | 6.34 | 6.63 | 6.11 | 6.46 | 1,160,067 | |
| 01/10/2025 | 6.48 | 6.57 | 6.23 | 6.50 | 1,317,119 | |
| 01/08/2025 | 7.00 | 7.08 | 6.61 | 6.69 | 1,800,482 | |
| 01/07/2025 | 7.05 | 7.44 | 6.67 | 7.10 | 2,254,902 | |
| 01/06/2025 | 7.25 | 7.46 | 6.99 | 7.05 | 3,110,266 | |
| 01/03/2025 | 6.31 | 7.22 | 6.31 | 7.20 | 1,081,118 | |
| 01/02/2025 | 6.09 | 6.45 | 5.96 | 6.19 | 655,478 | |
| 12/31/2024 | 6.14 | 6.27 | 5.96 | 6.00 | 597,636 | |
| 12/30/2024 | 6.16 | 6.23 | 5.91 | 6.11 | 950,313 | |
| 12/27/2024 | 6.49 | 6.52 | 6.19 | 6.29 | 735,644 | |
| 12/26/2024 | 6.34 | 6.51 | 6.30 | 6.44 | 657,384 | |
| 12/24/2024 | 6.33 | 6.41 | 6.19 | 6.39 | 412,740 |
About Adaptive Biotechnologies Stock history
Adaptive Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adaptive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adaptive Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adaptive Biotechnologies stock prices may prove useful in developing a viable investing in Adaptive Biotechnologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 147.1 M | 135.5 M | |
| Net Loss | -180.2 M | -189.2 M |
Adaptive Biotechnologies Quarterly Net Working Capital |
|
Adaptive Biotechnologies Stock Technical Analysis
Adaptive Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Adaptive Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Adaptive Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Adaptive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adaptive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0949 | |||
| Jensen Alpha | 0.575 | |||
| Total Risk Alpha | 0.6977 | |||
| Sortino Ratio | 0.1474 | |||
| Treynor Ratio | 0.2047 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.